Skip to Main Content

Paper Details

Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
Ther Adv Neurol Disord
25
2016
Author NameAffiliation
Finn SellebjergRigshospitalet, University of Copenhagen
Diego Cadavid
Richard ReynoldsImperial College London, Hammersmith Hospital Campus
  • 1 - 3

Datasets

Release 1.2